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Objective: The study aimed to explore premorbid academic and social
functioning in patients with schizophrenia, and its associations with the
severity of negative symptoms and neurocognitive impairment.
Method: Premorbid adjustment (PA) in patients with schizophrenia was
compared to early adjustment in unaffected first-degree relatives and
healthy controls. Its associations with psychopathology, cognition, and
real-life functioning were investigated. The associations of PA with
primary negative symptoms and their two factors were explored.
Results: We found an impairment of academic and social PA in patients
(P ≤ 0.000001) and an impairment of academic aspects of early
adjustment in relatives (P ≤ 0.01). Patients with poor PA showed
greater severity of negative symptoms (limited to avolition after
excluding the effect of depression/parkinsonism), working memory,
social cognition, and real-life functioning (P ≤ 0.01 to ≤0.000001).
Worse academic and social PA were associated with greater severity of
psychopathology, cognitive impairment, and real-life functioning
impairment (P ≤ 0.000001). Regression analyses showed that worse PA
in the academic domain was mainly associated to the impairment of
working memory, whereas worse PA in the social domain to avolition
(P ≤ 0.000001).
Conclusion: Our findings suggest that poor early adjustment may
represent a marker of vulnerability to schizophrenia and highlight the
need for preventive/early interventions based on psychosocial and/or
cognitive programs.
P. Bucci1 , S. Galderisi1,
A. Mucci1, A. Rossi2, P. Rocca3,
A. Bertolino4, E. Aguglia5,
M. Amore6, I. Andriola4,
A. Bellomo7, M. Biondi8,
A. Cuomo9, L. dell’Osso10,
A. Favaro11, F. Gambi12,
G. M. Giordano1, P. Girardi13,
C. Marchesi14, P. Monteleone15,
C. Montemagni3, C. Niolu16,
L. Oldani17, F. Pacitti2 ,
F. Pinna18, R. Roncone19,
A. Vita20,21, P. Zeppegno22,
M. Maj1, Italian Network for
Research on Psychoses†
1Department of Psychiatry, University of Campania L.
Vanvitelli, Naples, 2Section of Psychiatry, Department of
Biotechnological and Applied Clinical Sciences,
University of L’Aquila, L’Aquila, 3Section of Psychiatry,
Department of Neuroscience, University of Turin, Turin,
4Department of Neurological and Psychiatric Sciences,
University of Bari, Bari, 5Department of Clinical and
Molecular Biomedicine, Psychiatry Unit, University of
Catania, Catania, 6Section of Psychiatry, Department of
Neurosciences, Rehabilitation, Ophthalmology, Genetics
and Maternal and Child Health, University of Genoa,
Genoa, 7Psychiatry Unit, Department of Medical
Sciences, University of Foggia, Foggia, 8Department of
Neurology and Psychiatry, Sapienza University of Rome,
Rome, 9Department of Molecular Medicine and Clinical
Department of Mental Health, University of Siena,
Siena, 10Section of Psychiatry, Department of Clinical
and Experimental Medicine, University of Pisa, Pisa,
11Department of Neurosciences, Psychiatric Clinic,
University of Padua, Padua, 12Chair of Psychiatry,
Department of Neuroscience and Imaging, G. d’Annunzio
University, Chieti, 13Department of Neurosciences,
Mental Health and Sensory Organs, S. Andrea Hospital,
Sapienza University of Rome, Rome, 14Department of
Neuroscience, Psychiatry Unit, University of Parma,
Parma, 15Chair of Psychiatry, Department of Medicine
and Surgery, University of Salerno, Salerno, 16Chair of
Psychiatry, Department of Systems Medicine, Tor
Vergata University of Rome, Rome, 17Department of
Psychiatry, University of Milan, Milan, 18Section of
Psychiatry, Department of Public Health, Clinical and
Molecular Medicine, University of Cagliari, Cagliari,
Significant outcomes
• The presence of a mild impairment of academic functioning dur-
ing early life epochs in unaffected relatives of patients with
schizophrenia suggests that poor early adjustment in this domain
may represent a marker of vulnerability to schizophrenia.
• When considering primary negative symptoms, poor premorbid
adjustment was more strongly associated to avolition than to
poor emotional expression.
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Introduction
In line with the neurodevelopmental hypothesis of
schizophrenia, a poor premorbid adjustment has
been widely reported in individuals affected by the
disorder (1–3). Moreover, an impairment of func-
tioning in early epochs of life has been described in
unaffected relatives of patients with schizophrenia
as compared to healthy controls (4–8).
A worse premorbid adjustment in patients with
schizophrenia is associated with severity of nega-
tive symptoms, neurocognitive impairment, and
poor functional outcome (8–13). To further char-
acterize these associations, several studies explored
them by taking into account the distinction of pre-
morbid functioning in two separate subdomains
(i.e. the academic and the social one) and/or in dif-
ferent patterns of progression over time (i.e.
‘stable-poor’, ‘deteriorating’, and ‘stable-good’);
however, findings in this regard are not consistent
across studies, as summarized below.
The severity of negative symptoms has been
associated either with the social subdomain only
(8, 10, 14–20) or with both academic and social
aspects of premorbid functioning (21–25). More-
over, some studies reported an association of nega-
tive symptoms with specific patterns of progression
of premorbid adjustment over time, mainly the
‘stable-poor’ and/or the ‘deteriorating’ one (10, 15,
26); a lack of specificity has also been reported
(27).
Heterogeneity in findings on the association
between premorbid adjustment and negative
symptoms may be due, at least in part, to the
lack of distinction between primary (etiologically
related to the core pathophysiology of the syn-
drome) and secondary negative symptoms, that
was taken into account in few studies so far (8,
19, 25, 27, 28). Furthermore, according to recent
literature, negative symptoms include at least
two factors, avolition and poor emotional
expression, that might be underpinned by differ-
ent pathophysiological substrates (29, 30) and
show different correlates (31, 32). So far, no
study investigated separately the relationships of
poor premorbid adjustment with the two factors
of negative symptoms.
While for negative symptoms the association
with poor premorbid adjustment has been
consistently reported, and further research is
needed to clarify specific aspects of this relation-
ship, whether positive symptoms are related with
premorbid adjustment is still unclear as an associa-
tion has been reported in some studies (33–35), but
not in others (21, 36).
The severity of neurocognitive impairment has
been mainly associated with the academic domain
of premorbid adjustment (10, 15, 20, 21, 37–39),
although in some studies deficits of some cogni-
tive domains, such attention and executive func-
tions, have been found more closely related to the
social than to the academic aspects of premorbid
adjustment (40, 41). The specific cognitive deficits
found in association with premorbid adjustment
are extremely heterogeneous in the different
studies.
As to the association with poor functional out-
come, more often premorbid adjustment has been
associated with global functioning or with the
Limitations
• The evaluation of early functioning was retrospective, which
may involve a recall bias.
• The inclusion of parents together with siblings in the group of
relatives introduces a potential confounding effect in the compar-
isons between patients, relatives, and healthy controls.
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majority of explored areas of functioning, whereas
a consistent pattern of associations with specific
areas of functioning has not been described
(42–46).
In the light of the strong link between premorbid
adjustment and neurodevelopmental aspects of the
disorder, as well as of the above-reported contro-
versial findings and open issues, in this study we
tried to address the following questions: (i) Is the
functional impairment observed in patients before
the onset of schizophrenia also observed in their
unaffected first-degree relatives during early epochs
of life? If yes, does it involve both domains of
adjustment? (ii) Are distinct patterns of premorbid
adjustment course (i.e. ‘stable-good’, ‘stable-poor’,
‘deteriorating’) associated with the same psy-
chopathological and neurocognitive domains? (iii)
Is there a relationship between premorbid adjust-
ment and primary negative symptoms? Is it rele-
vant to both factors of negative symptoms
(avolition and poor emotional expression)? (iv)
Are different domains of premorbid adjustment
related to different negative symptoms factors and/
or to different cognitive domains? (v) Is premorbid
adjustment related to positive symptoms? (vi) Do
different domains of premorbid adjustment have a
different impact on specific areas of real-life func-
tioning?
Aims of the study
This study was aimed at exploring whether aca-
demic and social functioning during early epochs of
life are impaired in a large sample of community-
dwelling patients with schizophrenia, as well as in
their unaffected first-degree relatives, with respect
to healthy controls. In the group of patients, the
associations of early functioning with the two dis-
tinct factors of primary negative symptoms, avoli-
tion and poor emotion expression, as well with
neurocognition, social cognition and domains of
real-life functioning were also investigated.
Methods
Study design
Premorbid adjustment in the group of patients was
compared to adjustment in early age periods (early
adjustment) of a group of their unaffected first-
degree relatives and one of healthy controls. In the
group of patients, the associations of premorbid
adjustment with psychopathology, neurocognition,
social cognition, and real-life functioning were
investigated. The impact of premorbid adjustment
on primary negative symptoms, selected by
excluding the confounding effect of depression
and/or parkinsonism, as well as on the two distinct
factors, avolition and poor emotional expression,
was also explored.
Subjects
Patients were recruited among those consecutively
seen at the outpatient units of 26 Italian university
psychiatric clinics and/or mental health depart-
ments from March 2012 to September 2013.
Inclusion criteria were a diagnosis of schizophre-
nia according to DSM-IV, confirmed with the
Structured Clinical Interview for DSM-IV -
Patient version (SCID-I-P), and an age between 18
and 66 years. Exclusion criteria were as follows: (i)
history of head trauma with loss of consciousness;
(ii) history of moderate to severe mental retarda-
tion or of neurological diseases; (iii) history of
alcohol and/or substance abuse in the last
6 months; (iv) current pregnancy or lactation; (v)
inability to provide an informed consent; (vi) treat-
ment modifications and/or hospitalization due to
symptom exacerbation in the last 3 months.
For each recruited patient who agreed to involve
relatives, two unaffected first-degree relatives were
recruited, when available. They were, in order of
preference, the two parents, or one parent and one
sibling, or two siblings. Healthy controls were
recruited through flyers from the community at the
same sites as the patient sample. Exclusion criteria
for relatives and controls were the same as listed
above for patients from (i) to (v), plus a current or
lifetime Axis I or II psychiatric diagnosis, as
assessed with the SCID-I-Non Patient version and
the SCID-II.
All subjects signed a written informed consent to
participate after receiving a comprehensive expla-
nation of the study procedures and goals.
Procedures
The study has been conducted in accordance with
the principles of the Declaration of Helsinki (59th
World Medical Association General Assembly;
October 2008). Approval of the study protocol was
obtained from the Ethics Committees of the partic-
ipating centers.
Assessments
Premorbid characteristics. The assessment of pre-
morbid functioning in patients, as well as of early
adjustment in relatives and controls, was carried
out using the Premorbid Adjustment Scale (PAS)
(47). This instrument assesses five psychosocial
3
Premorbid adjustment in schizophrenia
domains (sociability and withdrawal, peer relation-
ships, scholastic performance, adaptation to
school, and social-sexual functioning), and four
age periods (childhood up to 11 years, early ado-
lescence from 12 to 15 years, late adolescence from
16 to 18 years, and adulthood from 19 years on).
Social-sexual functioning is not measured during
childhood, whereas school adaptation and school
performance are not assessed during adulthood. A
more global, ‘General’ section is included, contain-
ing items meant to estimate the overall function-
ing, for the entire period prior to the first episode,
in nine areas (education, employment or school,
change in work or school performance between
1 year and 6 months and between 3 years and
6 months before onset, independence, highest level
of functioning, social-personal adjustment, degree
of interest in life, and energy level).
Ratings are made on a 0- to six-point Likert
scale, with 0 indicating normal adjustment and six
indicating severe impairment. To gather informa-
tion about the premorbid period, a semi-structured
interview with the participant and her/his family
members was used. The PAS defines as ‘premor-
bid’ the period ending 6 months before the first
episode of illness.
In this study, the following criteria were adopted
to analyze the PAS data: (i) scores for the adult
age period were not analyzed in order to minimize
possible contamination with early prodromal and
psychotic symptoms of the illness; (ii) as suggested
by other authors (27), the final ‘General’ section
was not analyzed, because regarded as less reliable
than the others; (iii) according to the procedure
followed in previous studies (19, 37), separate
scores were calculated for social and academic pre-
morbid domains of functioning at each age level,
by averaging the items sociability, withdrawal,
peer relationships, and social-sexual functioning
for the social domain and the items scholastic per-
formance and adaptation to school for the aca-
demic domain; an academic and a social mean
score were then calculated by averaging the scores
of the considered age period for each of the two
domains; (iv) as in several previous studies (10, 26,
27), the course of premorbid functioning was clas-
sified into three different patterns: deteriorating,
stable-good, and stable-poor, according to the cri-
teria proposed by Haas and Sweeney (48). The
deteriorating pattern was defined as a progressive
decline characterized by a worsening in the PAS
global score (sum of scores divided by the highest
possible score within each age period) of at least
two points between childhood and adulthood, or a
proportionate decline for cases in which illness
onset was before late adolescence or adulthood
(i.e. a change between age groups of at least 0.66).
The remaining cases were regarded as stable, and
the median value of the PAS global score (0.34 in
our study) was used as a cutoff point to categorize
the subjects as stable-good or stable-poor.
Psychopathology. The Positive and Negative Syn-
drome Scale (PANSS) was used to rate symptom
severity. Scores for the dimension ‘positive symp-
toms’ were calculated according to Wallwork et al.
(49) by summing the scores for delusions, halluci-
natory behavior, grandiosity, and unusual thought
content.
Negative symptoms were assessed using the
Brief Negative Symptom Scale (BNSS) (50), an
instrument designed to overcome the problem of
heterogeneity of these symptoms. In fact, in line
with previous research (50, 51), this instrument
allows the identification of two separate factors:
avolition, consisting of anhedonia, asociality and
avolition, and poor emotional expression, includ-
ing blunted affect and alogia. The Italian version
of the scale was validated as part of the Italian
Network project (52).
The assessment of depressive and extrapyrami-
dal symptoms was carried out to exclude that neg-
ative symptoms were secondary to them. The
Calgary Depression Scale for Schizophrenia
(CDSS) (53) was used to assess depressive symp-
toms. This includes nine items (depression, hope-
lessness, self-depreciation, guilty ideas of reference,
pathological guilt, morning depression, early wak-
ening, suicide, observed depression), each rated
from 0 (absent) to 3 (severe). Ratings >6 on the
total score indicate clinically significant depression
(53). The St. Hans Rating Scale (SHRS) (54) was
used to investigate the presence of extrapyramidal
symptoms. This is a multidimensional rating scale
comprising four subscales: hyperkinesia, parkin-
sonism, akathisia, and dystonia. Each subscale
includes one or more items, with a score ranging
from 0 (absent) to 6 (severe). Clinically significant
extrapyramidal symptoms, which might confound
the assessment of negative symptoms, were defined
by a ‘mild’ (two) rating on at least three items, or a
‘mild’ rating for tremor or rigidity plus a ‘mild’ rat-
ing on at least another item, or a ‘mild-moderate’
(three or more) rating on at least one item.
Bradykinesia and reduced facial expression were
not included among confounding symptoms, due
to the high probability that their presence repre-
sents a sign of diminished expression.
Neurocognition. The Measurement and Treatment
Research to Improve Cognition in Schizophrenia
(MATRICS) Consensus Cognitive Battery
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(MCCB) was used for neurocognitive assessment,
as it is regarded as the ‘state-of-the-art’ neuropsy-
chological battery for research purposes in
schizophrenia (55, 56). This battery includes tests
for the assessment of six distinct cognitive
domains: processing speed, attention/vigilance,
working memory, verbal learning, visual learning,
reasoning, and problem solving.
Social cognition. The assessment of social cogni-
tion, partly carried out by the MCCB Mayer-Salo-
vey-Caruso Emotional Intelligence Test
(MSCEIT) managing emotion section, was inte-
grated by the Facial Emotion Identification Test
(FEIT) (57), which examines emotion perception,
and The Awareness of Social Inference Test
(TASIT) (58), which is a theory of mind test con-
sisting of seven scales (positive emotions, negative
emotions, sincere, simple sarcasm, paradoxical sar-
casm, enriched sarcasm, lie), organized into three
sections: emotion recognition, social inference-
minimal, and social inference-enriched.
Real-life functioning. Real-life functioning was
assessed by means of the Specific Levels of Func-
tioning Scale (SLOF) (59, 60), an instrument
endorsed by the panel of experts involved in the
Validation of Everyday Real-World Outcomes
(VALERO) initiative as a suitable measure explor-
ing different domains of functioning (61, 62). The
following domains, characterized by a sufficient
level of variability, were analyzed: interpersonal
relationships, community activities (e.g. shopping,
using public transportation), and working abilities.
Higher scores correspond to better functioning.
Data analysis. Co-norming and standardization of
the Italian MCCB test scores was carried out as
described in Kern et al. (55, 63). For cognitive
domains including more than one measure, that is
working memory and speed of processing, the
summary score for the domain was calculated by
summing the scores of the tests included in that
domain and then standardizing the sum to a T-
score. In this way, all test scores and domain scores
were standardized to the same measurement scale
with a mean of 50 and standard deviation of 10.
Social cognition variables were standardized with
respect to Italian normative data. The mean of
standardized scores of MSCEIT, FEIT, and
TASIT was used as a composite score. All the
other variables were transformed into z-scores.
Differences among groups on categorical vari-
ables (gender distribution and PAS course catego-
rization) were investigated by using Pearson’s chi
square test.
Independent one-way analyses of variance (ANO-
VAs) were used to test group differences on demo-
graphic variables. In case of group differences on
these indices, group comparisons were performed
by entering them as covariates. An exception was
made for education, as its assessment is included in
the PAS and there is an overlap between premor-
bid adjustment and educational level (12, 64).
Multivariate analyses of variance (MANOVAs)
were run to investigate: (i) differences on indices of
early adjustment among patients, relatives, and
controls, as well as among parents and siblings
within the group of relatives in order to control for
the possible confounding effect related to the older
age and lower education of parents; (ii) differences
between patient groups with different premorbid
adjustment course (stable-good, stable-poor, and
deteriorating) with respect to psychopathology,
neurocognition, social cognition, functional out-
come, and PAS academic and social profiles. When
a group difference or an interaction between
groups and domains was statistically significant,
univariate effects were examined using Sheffe’s post
hoc test.
To investigate the associations of premorbid
adjustment with psychopathological, cognitive,
and real-life functioning indices, correlation analy-
ses were carried out by means of Pearson’s test.
Furthermore, stepwise multiple regression analyses
were run, in which mean scores of PAS academic
and social domains were entered as dependent
variables, whereas independent variables included
gender, as well as psychopathological dimensions
and cognitive indices which differed between
patient subgroups with different premorbid adjust-
ment course.
Results
Subjects
The study was carried out in a large sample of
community-dwelling patients with a DSM-IV diag-
nosis of schizophrenia (n = 915), as well as in a
group of their unaffected first-degree relatives
(n = 368: 249 parents, 119 siblings) and one of
healthy controls (n = 778) in the context of the
multicenter study of the Italian Network for
Research on Psychoses (65). Group comparisons
on demographic variables showed a higher fre-
quency of male gender among patients (69.4%)
with respect to both relatives and controls (42.9%
and 48.4%, respectively; P ≤ 0.000001), an older
age in relatives (55.0  13.7 years) with respect to
patients and controls (40.2  10.7 and
40.5  12.5 years, respectively; P ≤ 0.00002), due
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to the fact that also parents were included in the
group of relatives (mean age: 61.5  8.4 years for
parents, 41.3  12.6 years for siblings;
P ≤ 0.000001), and a higher education level in con-
trols (13.0  4.0 years) than in patients and rela-
tives (11.6  3.4 and 11.3  4.0 years,
respectively; P ≤ 0.00002). In subsequent compar-
isons among the three groups, gender and age were
used as covariates, whereas education was not, as
reported in the Methods section.
Comparisons on demographic variables among
patients with different premorbid adjustment
course (stable-good, n = 329; stable-poor, n = 329;
deteriorating, n = 249) showed that age and gender
distribution were comparable, whereas education
was higher in the stable-good subgroup compared
with the other two.
Group comparisons between patients, unaffected relatives, and
healthy controls on PAS indices
The MANOVA on PAS academic and social dimen-
sions comparing patients, relatives, and controls
showed a significant group effect (F2,1677 = 524.83,
P ≤ 0.000001), due to a poorer early adjustment in
patients with respect to both controls and relatives
for both PAS domains and for all age periods
(Fig. 1a).
Moreover, a statistically significant group-by-
age period interaction (F4,3354 = 90.46,
P ≤ 0.000001) was observed. According to the post
hoc analysis, it was due to a significant worsening
of premorbid adjustment over time (childhood vs.
early adolescence as well as early vs. late adoles-
cence), independently of the PAS domain, in the
group of patients, whereas such a progression was
not observed in the other two groups (Fig. 1a).
A significant interaction group-by-dimension
was also observed (F2,1677 = 28.89, P ≤ 0.000001)
that, according to post hoc analysis, was due to a
greater impairment in patients with respect to the
other two groups for both domains, and to a
poorer functioning in relatives with respect to con-
trols only for the academic domain, independently
by the age period (Fig. 1b).
The MANOVA on PAS academic and social
dimensions comparing parents and siblings within
the group of relatives showed no statistically signif-
icant interaction with kinship.
The comparisons among the three groups on the
frequency of different patterns of course of early
adjustment showed that a poor early adjustment
was more frequent in patients (63.7%) with respect
to relatives and controls (9.5% and 5.4%, respec-
tively; P ≤ 0.00001) and, to a less degree, in rela-
tives with respect to controls (P ≤ 0.01).
Comparisons among patient groups with different course of
premorbid adjustment
Comparisons among the three subgroups of
patients with different course of premorbid adjust-
ment revealed the lack of differences for all the
investigated psychopathological, cognitive, and
real-life functioning indices between patients with
the stable-poor pattern and those with the deterio-
rating one. Therefore, these two subgroups were
collapsed in a single class named ‘poor premorbid
adjustment’ (poor-PA, n = 578) that was com-
pared to the remaining one named ‘good premor-
bid adjustment’ (good-PA, n = 329). The only
difference between the two subgroups on demo-
graphic variables was a higher level of education in
the good-PA with respect to the poor-PA group.
The MANOVA on psychopathological variables com-
paring poor-PA vs. good-PA patients showed a
significant group effect (F1,905 = 33.04,
P ≤ 0.000001) and a significant group-by-symptom
interaction (F2,1810 = 4.02, P ≤ 0.02), due to a
greater severity of both negative symptoms subdo-
mains (poor emotional expression and avolition)
in the poor-PA group (Fig. 2a).
When the MANOVA was run in the subsample
without clinically significant depression and/or
parkinsonism (n = 480), significant effects of group
(F1,478 = 19.32, P ≤ 0.000001) and of symptom
subdomain (F2,956 = 4.86, P ≤ 0.01) were
observed, whereas the group-by-symptom domain
interaction only approached the statistical signifi-
cance (F2,956 = 2.65, P ≤ 0.07). Post hoc analysis in
this subsample revealed a statistically significant
greater severity of avolition only in the poor-PA
group (Fig. 2b).
The MANOVA on neurocognitive domains showed
a significant effect of group (F1,860 = 16.58,
P ≤ 0.00005) and domain (F5,4300 = 62.44,
P ≤ 0.000001), and a significant group-by-domain
interaction (F5,4300 = 2.17, P ≤ 0.05) that, according
to post hoc analysis, was due to a more severe
impairment of working memory in the poor-PA
group with respect to the good-PA one (Table 1).
The MANOVA on the social cognition index showed a
significant effect of group (F1,897 = 8.15, P ≤ 0.004),
due to a greater impairment in the poor-PA group
with respect to the good-PA one (Table 1).
A pattern of group differences analogous to
those reported above emerged by the MANOVA run
on SLOF areas, showing a significant group effect
(F1,885 = 46.29, P ≤ 0.000001) and a significant
group-by-area effect (F2,1770 = 3.32, P ≤ 0.04).
Post hoc analyses showed a greater impairment of
all the considered areas of real-life functioning in
poor-PA with respect to good PA (Table 1).
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Correlation analyses in the patient sample
Results of correlation analyses are reported in
Table 2. Statistically significant positive correla-
tions were observed between both academic and
social PAS domains and the three considered
psychopathological indices (poor emotional
expression, avolition, and positive symptoms;
P ≤ 0.0001 for all of them), indicating that a
worse premorbid adjustment is associated to
more severe psychopathology. The association
was slightly stronger for avolition (r = 0.16)
with respect to the other two symptom dimen-
sions (r = ≤0.13), in particular in the subsample
of patients without clinically significant depres-
sion and/or parkinsonism (n = 482; r = 0.32 for
avolition, r ≤ 0.26 for the remaining two
dimensions).
All neurocognitive domains, as well as the social
cognition index, were negatively correlated with
both PAS domains. These correlations indicate that
a worse premorbid adjustment is associated to a
worse neurocognitive and social cognition perfor-
mance. They were statistically significant for all neu-
rocognitive domains (P ≤ 0.0001 for all of them)
and for social cognition (P ≤ 0.0001) when consid-
ering the academic PAS domain, and only for speed
of processing, working memory, verbal learning,
and reasoning and problem solving (P ≤ 0.0001 for
all of them) when considering the social PAS
domain. In the subsample of patients without
depression and/or parkinsonism, the same pattern
of results was observed for the academic domain,
whereas for the social domain the only statistically
significant association was with working memory.
PAS academic PAS social
(b)
(a)
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#
Fig. 1. Group comparisons on PAS Academic and Social dimensions. (a) Patients show a greater impairment with respect to both
healthy controls and unaffected relatives for both PAS domains, in all age periods, as well as a highly significant worsening over time,
not observed in the other two groups. *Statistically significant difference with respect to unaffected relatives and healthy controls:
P < 0.000001. §Statistically significant difference with respect to the previous age period: P < 0.000001. (b) A greater impairment is
observed, independently from age periods, in patients with respect to the other two groups for both Academic and Social PAS
domain, as well as in unaffected relatives with respect to healthy controls only for the Academic domain. *Statistically significant dif-
ference with respect to unaffected relatives and healthy controls: P < 0.000001. #Statistically significant difference with respect to
healthy controls: P < 0.01.
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Statistically significant negative correlations
were also observed between both PAS domains
and the three SLOF areas (P ≤ 0.0001 for all of
them), indicating that a worse premorbid adjust-
ment is associated to worse real-life functioning in
all the examined domains. Slightly stronger associ-
ations were observed between the PAS academic
domain and work abilities (r = 0.23 vs.
r ≤ 0.17), as well as between social PAS domain
and interpersonal relationships (r = 0.27 vs.
r ≤ 0.19). This pattern of correlations did not
change after the exclusion of patients with clini-
cally significant depression and/or parkinsonism.
Stepwise multiple regression analyses in the patient sample
Results of multiple regression analyses are
reported in Table 3. The mean score on the PAS
academic domain was associated with the working
memory neurocognitive domain (F3,868 = 87.8,
R2 = 0.09), avolition (F3,868 = R
2 = 0.01), and
gender (F3,868 = 7.7, R
2 = 0.008) (the worse the
academic premorbid adjustment, the poorer the
performance on the tests exploring working mem-
ory, the more severe the avolition, and the higher
the percentage of males). The mean score on the
PAS social domain was associated with avolition
(F2,894 = 74.6, R
2 = 0.08) and working memory
(F2,894 = 17.3, R
2 = 0.02) (the worse the social pre-
morbid adjustment, the more severe the avolition,
and the poorer the performance on working mem-
ory test). After excluding subjects with clinically
significant depression and/or parkinsonism, the
association between academic PAS domain and
working memory, as well as that between social
PAS domain and avolition, became slightly stron-
ger (R2 = 0.10 for both).
Discussion
According to our findings, premorbid adjustment
in patients with schizophrenia, as compared to
(a)
(b)
Whole group
Subsample of patients without 
depression and/or parkinsonism
–0.6
–0.5
–0.4
–0.3
–0.2
–0.1
0.0
0.1
0.2
POS EMO-EXPR AVO
z-
sc
or
es
–0.6
–0.5
–0.4
–0.3
–0.2
–0.1
0
z-
sc
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Good-PA
Poor-PA
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Good-PA
Poor-PA
* 
***
**
Fig. 2. Comparisons on psychopathological variables between patients with good premorbid adjustment (Good-PA) and patients
with poor premorbid adjustment (Poor-PA). (a) In the whole sample of patients, both domains of negative symptoms (Poor Emo-
tional expression and Avolition) are more severe in the poor-PA group with respect to the good-PA one. (b) After the exclusion of
patients with clinical significant depression and/or parkinsonism, only Avolition is more severe in the poor-PA group with respect to
the good-PA one. POS = positive symptoms; EMO-EXPR = Reduced emotional expression; AVO = Avolition. *Statistically signif-
icant group difference: *P ≤ 0.003; **P ≤ 0.0005; ***P ≤ 0.00001.
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early adjustment in healthy controls and patients’
unaffected first-degree relatives, is poorer for both
social and academic domains during childhood
and early and late adolescence. This finding is in
line with a large body of literature reporting an
impairment of premorbid adjustment in patients
with schizophrenia with respect to healthy controls
(64, 66, 67).
Unaffected relatives also differed from healthy
controls, although to a lesser extent than patients,
by showing a poorer early adjustment only for the
academic domain and independently of the age
period, as well as a slightly greater frequency of
poor early adjustment. These findings, in line with
those of other studies exploring early adjustment
in patients’ relatives (4–8, 64), support the hypoth-
esis that poor early adjustment may represent a
marker of vulnerability to schizophrenia.
The exclusive involvement of the academic
domain in relatives, already reported by other
authors (4, 5), could be related to a mild cognitive
dysfunction that has been described by several
authors (68–73) and found in the sample of rela-
tives recruited in the present multicenter study (63,
74).
It should be noticed that the differences in early
adjustment we observed between relatives and con-
trols were small, although statistically significant.
An underestimation of impairment in early epochs
of life in relatives cannot be excluded; it might be
due to a retrospective recall bias that could be
greater in this group since it includes also parents
(for which a long time elapsed since early epochs
of life and no further source of information was
available). As a matter of fact, more marked differ-
ences were reported when the group of relatives
consisted of offspring of patients (5). It should be
acknowledged that the inclusion of parents
together with siblings in the group of relatives rep-
resents a limitation of our study design, as it intro-
duces a potential bias due to the fact that parents
are older and less educated than siblings; therefore
we controlled for this potential bias by comparing
PAS severity among parents and siblings, and
Table 1. Comparisons on cognitive domains and areas of real life functioning
between patients with good premorbid adjustment (good-PA) and patients with poor
premorbid adjustment (poor-PA)
Patients with
good-PA
(n = 329)
Patients with
poor-PA
(n = 578)
Psychopathological domains (z-scores)
PANSS positive 0.11  1.01 0.07  0.98
BNSS reduced emotional expression 0.18  1.02 0.11  0.98*
BNSS avolition 0.25  1.04 0.16  0.94**
Neurocognitive domains (T-scores)
Speed of processing 33.27  10.25 30.50  11.75
Attention/vigilance 37.83  11.31 36.36  11.43
Working memory 37.73  11.38 33.53  11.90*
Verbal learning 36.69  10.85 34.36  12.20
Visual learning 33.58  15.05 31.44  14.51
Problem solving 39.19  10.45 36,85  9.92
Social cognition (composite score) 1.26  1.15 1.47  1.08*
Areas of real-life functioning (z-scores)
Interpersonal relationships 0.26  0.97 0.16  0.97**
Community activities 0.17  0.95 0.10  1.01**
Work abilities 0.28  0.15 0.15  0.99**
PANSS, Positive and Negative Syndrome Scale; BNSS, Brief Negative Symptom
Scale.
Statistically significant group difference: *P ≤ 0.01; **P ≤ 0.00001.
Table 2. Results of correlation analyses
Whole-patient sample (n = 915) Subsample of patients without depression and/or parkinsonism (n = 482)
PAS academic PAS Social PAS academic PAS social
P r P r P r P r
Psychopathology
Reduced emotional expression 0.0001 0.13 0.0001 0.22 0.01 0.11 0.0001 0.26
Avolition 0.0001 0.16 0.0001 0.28 0.0001 0.17 0.0001 0.32
Positive symptoms 0.0001 0.12 0.0001 0.14 0.01 0.12 0.002 0.14
Cognition
Speed of processing 0.0001 0.20 0.0001 0.14 0.0001 0.21 0.1 0.07
Attention/vigilance 0.0001 0.16 0.07 0.06 0.002 0.15 0.6 0.02
Working memory 0.0001 0.30 0.0001 0.18 0.0001 0.32 0.0001 0.16
Verbal learning 0.0001 0.19 0.0001 0.10 0.0001 0.21 0.07 0.08
Visual learning 0.0001 0.18 0.06 0.06 0.0001 0.40 0.4 0.04
Problem solving 0.0001 0.14 0.0001 0.11 0.001 0.15 0.1 0.07
Social cognition 0.0001 0.19 0.1 0.05 0.0001 0.22 0.1 0.08
Real-life functioning
Interpersonal relationships 0.0001 0.16 0.0001 0.27 0.0001 0.19 0.0001 0.27
Community activities 0.0001 0.17 0.0001 0.19 0.0001 0.19 0.0001 0.18
Work abilities 0.0001 0.23 0.0001 0.18 0.0001 0.21 0.0001 0.18
Bold, statistically significant.
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found no statistically significant interaction with
kinship.
Our data also confirm the previously reported
impact of poor premorbid adjustment on negative
symptoms (9, 11, 75) but not on the positive ones
(21, 36). In this study, for the first time to our
knowledge, the impact of premorbid dysfunction
was investigated on the two factors of the negative
psychopathological dimension, that is avolition
and poor emotional expression. When considering
the subsample of patients without clinically signifi-
cant depression and/or parkinsonism, we found a
greater severity of avolition in the poor-PA group
with respect to the good-PA one, and an associa-
tion of academic and social premorbid impairment
with both negative factors. Furthermore, regres-
sion analyses revealed the lack of associations
between the two PAS domains and the negative
factor poor emotional expression, whereas both
academic and social PAS domains were signifi-
cantly associated with avolition; this association
resulted slightly stronger with the social PAS
domain, in particular after excluding the con-
founding effect of depression and/or parkinsonism.
These findings are in line with the hypothesis that
the two distinct dimensions of negative symptoms
are subtended by different pathophysiological
mechanisms and neurobiological correlates.
According to recent literature, a key role in the
pathophysiology of poor emotional expression
seems to be played by a dysfunction of amygdala
and hippocampus, known to be involved in emo-
tion recognition and expression, whereas avolition
has mainly been associated with abnormalities in
prefrontal-subcortical circuits involved in motiva-
tion and goal-directed behaviour (32, 76), and is a
much stronger predictor of functioning than is
poor emotional expression (77, 78). Our finding of
a stronger association of poor premorbid function-
ing, especially of its social component, with avoli-
tion than with poor emotional expression, suggests
that the former is more likely related to neurode-
velopmental abnormalities with respect to the lat-
ter and that such abnormalities may involve neural
circuits implicated in goal-oriented behavior.
A greater impairment of working memory and
social cognition was observed in patients with
poor-PA with respect to those with good-PA. An
association between premorbid dysfunction and
impairment in working memory has already been
reported (10, 39), whereas the relationship between
social cognition and premorbid adjustment was
explored for the first time in this study. Different
patterns of association of poor-PA with other neu-
rocognitive domains have also been found (15, 21,
79, 80). Such discrepancies may be related to the
great heterogeneity among different studies in the
choice of the test battery and selection of cognitive
domains.
Regression analyses showed that working mem-
ory was more strongly associated to the PAS aca-
demic domain than to the social one, especially in
the subsample of patients without clinically signifi-
cant depression and/or parkinsonism, whereas
avolition was more strongly related to the social
than to the academic PAS domain. These two dif-
ferent patterns of associations have been reported
in the majority of previous studies (8, 10, 15–18,
20, 21, 37), with some exception (23–25, 40) and
are confirmed in this study when excluding the
confounding effect of depression and/or parkin-
sonism.
As to real-life functioning, we found that all the
investigated areas were more impaired in the group
of patients with poor-PA, and that their impair-
ment was associated to both PAS domains. This
confirms the impact of premorbid dysfunction on
real-life functioning, as reported by several authors
(42–46).
In conclusion, our findings confirm the presence
of a global impairment of premorbid adjustment in
patients and an impairment of early adjustment in
patients’ unaffected first-degree relatives mainly
involving the academic domain. Our data confirm
Table 3. Results of multiple regression analyses
Whole-patient
sample (n = 915)
Subsample of patients
without depression/
parkinsonism (n = 482)
F3,868 R
2 F3,454 R
2
PAS Academic
Gender 7.7 0.008** 9.4 0.02**
Reduced emotional expression
Avolition 12.8 0.01** 4.8 0.01*
Attention/vigilance
Working memory 87.8 0.09*** 51.9 0.10***
Verbal learning
Visual learning
Problem solving
Social cognition index
Whole-patient
sample (n = 915)
Subsample of patients
without depression/
parkinsonism (n = 482)
F2,894 R
2 F2,473 R
2
PAS social
Gender
Reduced emotional expression
Avolition 74.6 0.08*** 55.8 0.10***
Working memory 17.3 0.02*** 6.02 0.01*
Verbal learning
Problem solving
*P ≤ 0.05; **P ≤ 0.005; ***P ≤ 0.0001.
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that the two PAS domains show different patterns
of associations, with the academic domain mainly
associated with cognitive deficits, in particular
working memory, and the social domain mostly
associated with primary negative symptoms, in
particular avolition. Instead, premorbid adjust-
ment domains are not associated with the severity
of positive symptoms, whereas both of them are
associated with social cognition and real-life func-
tioning.
The impairment of functioning occurring in
patients before the illness onset, as well as in their
unaffected relatives during early epochs of life, sug-
gests that poor early adjustment may represent a
marker of vulnerability to schizophrenia. How-
ever, the possibility that it is a consequence of cog-
nitive deficits and/or avolition cannot be ruled out
based on available findings.
Findings from our study have some potential
clinical implications. First of all, they suggest the
inclusion of a comprehensive assessment of aca-
demic and social aspects of early functioning in
subjects at ultra-high-risk for developing psychosis
in algorithms implemented to predict psychosis. In
addition, such an assessment of early functioning
in these subjects, as well as its historical assessment
in patients at their first episode of psychosis, may
be informative for the implementation of individu-
ally tailored preventive/early intervention strate-
gies, such as psychosocial and/or cognitive
rehabilitation programs, based on the domain of
early functioning resulting impaired. Early inter-
ventions on social and/or academic aspects of
functioning may impact, respectively, the course of
negative symptoms and cognitive deficits, which in
their turn strongly influence the outcome in people
with schizophrenia.
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